Richard Buller
Förmögenhet: 829 950 $ per 2026-08-31
Förmögenhet: 829 950 $ per 2026-08-31
Richard E.
Buller is currently an Independent Director at Celcuity, Inc. since 2019.
Formerly, Dr. Buller was an Independent Director at Rebus Holdings, Inc. from 2016 to 2018.
Dr. Buller served as Director-Oncology Medicine Development Center at GSK Plc.
From 2009 to 2016, Dr. Buller was VP & Head-Clinical Development Oncology at Pfizer Inc. Dr. Buller was Vice President-Translational Medicine at Exelixis, Inc. Dr. Buller was Professor-Gynecologic Oncology at the University of Iowa.
Dr. Buller completed undergraduate studies at the University of California, Los Angeles and earned a doctorate from Baylor College of Medicine.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
CELCUITY INC. 0,02 % | 2026-06-10 | 9 319 ( 0,02 % ) | 829 950 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| CELCUITY INC. | Direktör/Styrelseledamot | 2019-12-03 |
| Företag | Position | Slut |
|---|---|---|
| INSPYR THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2018-02-09 |
| PFIZER INC. | Företagsledare/Principal | 2016-07-01 |
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
| GSK PLC | Företagsledare/Principal | - |
| EXELIXIS, INC. | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 8 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Exelixis, Inc.
Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Rebus Holdings, Inc.
Rebus Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of novel targeted precision therapeutics | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celcuity, Inc.
Celcuity, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company develops novel diagnostic tests | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån